TGM2 accelerates migration and differentiation of BMSCs by activating Wnt/ß-catenin signaling.
J Orthop Surg Res
; 18(1): 168, 2023 Mar 05.
Article
em En
| MEDLINE
| ID: mdl-36872331
ABSTRACT
BACKGROUND:
Transglutaminase 2 (TGM2) is a gene previously reported to be associated with the differentiation of bone marrow mesenchymal stem cells (BMSCs). The study was developed to reveal the impact of TGM2 on the migration and differentiation of BMSCs.METHODS:
Cells were isolated from bone marrow of mice and then the surface antigens were identified by flow cytometry. Wound healing assays were conducted to assess the migratory ability of BMSCs. The mRNA levels of TGM2 and osteoblast-associated genes (ALP, OCN, and RUNX2) were subjected to RT-qPCR analysis, and protein levels of these genes as well as ß-catenin were quantitated by western blotting. Alizarin red staining was conducted for detection of osteogenic ability. The activation of Wnt signaling was assessed by TOP/FOP flash assays.RESULTS:
Surface antigens were positively identified in MSCs, indicating good multidirectional differentiation ability of cells. TGM2 silencing suppressed BMSC migration while weakening mRNA and protein levels of osteoblast-associated genes. While TGM2 overexpression exerts the opposite impact on cell migration and expression levels of osteoblast-associated genes. Additionally, overexpressed TGM2 promotes the mineralization of BMSCs according to results of Alizarin red staining. Moreover, TGM2 activated the Wnt/ß-catenin signaling, and DKK1 (an inhibitor of Wnt signaling) reversed the promoting influence of TGM2 on cell migration and differentiation.CONCLUSION:
TGM2 promotes the migration and differentiation of BMSCs via activation of the Wnt/ß-catenin signaling.Palavras-chave
Texto completo:
1
Coleções:
01-internacional
Temas:
Geral
Base de dados:
MEDLINE
Assunto principal:
Células-Tronco Mesenquimais
/
Via de Sinalização Wnt
Idioma:
En
Revista:
J Orthop Surg Res
Ano de publicação:
2023
Tipo de documento:
Article
País de afiliação:
China